Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Completed Secondary Placing

9 Apr 2014 13:52

RNS Number : 4068E
Quixant PLC
09 April 2014
 



9 April 2014

Quixant Plc

("Quixant" or the "Company")

 

£25m placing of 17,857,143 existing Ordinary Shares

 

Quixant (AIM:QXT) a leading provider of specialised computing platforms for casino gaming machine applications, is pleased to announce that in order to satisfy market demand and broaden the institutional shareholder base of the Company, finnCap, as the Company's broker, have conducted an oversubscribed placing of 17,857,143 existing ordinary shares of 0.01p in the Company (the "Placing Shares" and the "Placing") with new and existing institutional investors.

 

The Placing Shares have been sold on behalf of certain directors of the Company and their connected persons (the "Director Vendors") and certain other founder shareholders of the Company (the "Vendor Shareholders"). The Placing Shares were sold at a price of 140 pence per share and represent, in aggregate, 27.6 per cent. of the issued share capital of Quixant.

 

The Director Vendors have been released by finnCap from the terms of their respective lock-in obligations, as set out in paragraph 15 of Part II of the Company's Admission Document dated 21 May 2013 (the "Admission Document") to the extent of the Placing Shares sold in the Placing. All ordinary shares held by the Director Vendors subsequent to the Placing will remain subject to the lock-in obligations and orderly market arrangements set out in the Admission Document. All ordinary shares held by the Vendor Shareholders subsequent to the Placing remain subject to the orderly marketing arrangements set out in paragraph 15 of Part II of the Admission Document.

 

Subsequent to the Placing, the Director Vendors revised shareholdings are set out below.

 

Director

Placing Shares sold

Resultant shareholding

 

Number of Ordinary Shares

% of issued share capital

Number of Ordinary Shares

% of Enlarged Share Capital

Nick Jarmany

8,109,347

12.5%

16,752,923(1)

25.9%

Gary Mullins

3,142,173

4.9%

4,058,641(2)

6.3%

Chen Tai Lin

2,221,739

3.4%

4,589,842(3)

7.1%

 

(1) Mr Jarmany's holding includes 5,573,379 Ordinary Shares, representing 8.6 per cent. of the issued share capital of the Company, registered in the name of his wife, Francesca Marzilli.

 

(2) Mr Mullins' holding includes 389,233 Ordinary Shares, representing 0.6 per cent. of the issued share capital of the Company, registered in the name of his wife, Sophie Jayne Mullins

 

(3) Mr Lin's holding includes 1,167,700 Ordinary Shares, representing 1.8 per cent. of the issued share capital of the Company, registered in the name of his wife, Shu-Hsiang Wu.

 

Subsequent to the Placing the Founder Shareholders revised shareholdings are set out below.

 

Vendor Shareholder

Placing Shares sold

Resultant shareholding

 

Number of Ordinary Shares

% of issued share capital

Number of Ordinary Shares

% of Enlarged Share Capital

Alex Taylor

1,269,565

2.0%

2,662,767

4.1%

Mark Mullins

2,380,434

3.7%

2,484,981

3.8%

Daniel Jarmany

407,714

0.6%

842,286

1.3%

Tim Moulson

326,171

0.5%

673,829

1.0%

 

Nick Jarmany, CEO of Quixant, commented: "Since our IPO in May last year it became increasingly clear to us that greater liquidity was necessary for the long term benefit of the Company. By successfully completing this Placing we have satisfied significant institutional demand and broadened our shareholder base. I am very pleased with the calibre and support of existing and new shareholders and look forward to continuing to implement our growth strategy."

 

Enquiries

 

Quixant plc

Nick Jarmany (Chief Executive)
Jon Jayal (General Manager)

+44(0)1223 892 696

 

Nominated Adviser and Broker:

finnCap Limited

Matt Goode (Corporate Finance)

Charlotte Stranner (Corporate Finance)

Victoria Bates (Corporate Broking)

 

 

+44(0)20 7220 0500

Financial PR:

Newgate Threadneedle

John Coles / Fiona Conroy / Hilary Millar

 

+44(0)20 7653 9850

 

 

About Quixant

Quixant, founded in 2005, designs and manufactures complete advanced hardware and software solutions (Gaming Platforms) for the pay-for-play gaming and slot machine industry. The Company is headquartered outside of Cambridge in the UK. Quixant UK Ltd is responsible for the group's global (excluding North America) sales function and its Las Vegas based subsidiary, Quixant USA Inc, is responsible for sales and sales support to the North American market. Quixant has its own manufacturing and engineering operation in Taiwan, which has evolved with the rapid growth of the Company. Quixant's Italian subsidiary, Quixant Italia, houses the Group's software engineering and customer support team.

 

Quixant's high quality, specialised products provide an all-in-one solution, based on PC technology but with augmentative hardware features and operating software developed specifically to address the requirements of the gaming industry. Products feature innovative mechanical designs which are optimised for operation in the gaming and slot machine environment. Quixant's proprietary hardware and embedded software is flexible in its design, enabling Quixant to easily respond to changes in regulation or customers operating in different markets or jurisdictions.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEUGUAWCUPCUQB
Date   Source Headline
10th Dec 20209:00 amRNSPrice Monitoring Extension
10th Dec 20207:00 amRNSTrading Update
17th Nov 20205:52 pmRNSHolding(s) in Company
27th Oct 20207:00 amRNSExercise of Options
14th Oct 20206:15 pmRNSHolding(s) in Company
13th Oct 20207:00 amRNSDirector Shareholding
12th Oct 20203:17 pmRNSGrant of Options
7th Oct 20205:26 pmRNSHolding(s) in Company
30th Sep 20207:00 amRNSInterim Results
19th Aug 20207:00 amRNSAppointment of Interim CFO
10th Aug 20207:00 amRNSChanges to the Board of Directors
23rd Jul 20204:45 pmRNSHolding(s) in Company
23rd Jul 20204:05 pmRNSHolding(s) in Company
22nd Jul 20207:00 amRNSTrading Update and Notice of Results
3rd Jul 20205:57 pmRNSHolding(s) in Company
3rd Jul 20205:57 pmRNSHolding(s) in Company
19th May 20204:21 pmRNSResult of AGM
19th May 20207:00 amRNSTrading Update
6th May 20204:41 pmRNSSecond Price Monitoring Extn
6th May 20204:35 pmRNSPrice Monitoring Extension
29th Apr 20204:42 pmRNSSecond Price Monitoring Extn
29th Apr 20204:36 pmRNSPrice Monitoring Extension
28th Apr 20207:00 amRNSDirector/PDMR Shareholding
27th Apr 20207:00 amRNSDesignate Director Shareholding
23rd Apr 20207:00 amRNSAppointment of Non-Executive Director
6th Apr 20207:00 amRNSAudited Final Results
3rd Apr 202012:23 pmRNSHolding(s) in Company
31st Mar 20207:00 amRNS2019 Trading and COVID-19 update
27th Mar 20203:08 pmRNSTiming of Results
26th Mar 20204:50 pmRNSBoard Change
19th Mar 202012:50 pmRNSHolding(s) in Company
18th Mar 20207:00 amRNSNotice of Results Update
12th Feb 20205:44 pmRNSHolding(s) in Company
29th Jan 20207:00 amRNSTrading Update and Notice of Results
20th Dec 20195:50 pmRNSHolding(s) in Company
24th Oct 20194:13 pmRNSDirector/PDMR Shareholding
22nd Oct 20193:05 pmRNSHolding(s) in Company
22nd Oct 20193:05 pmRNSHolding(s) in Company
14th Oct 20194:10 pmRNSDirector/PDMR Shareholding
7th Oct 20195:14 pmRNSDirector/PDMR Transfer Shareholding
27th Sep 20193:41 pmRNSHolding(s) in Company
23rd Sep 20193:09 pmRNSDirector/PDMR Shareholding
19th Sep 20194:13 pmRNSDirector/PDMR Shareholding
18th Sep 20194:54 pmRNSDirector/PDMR Shareholding
17th Sep 20199:05 amRNSSecond Price Monitoring Extn
17th Sep 20199:00 amRNSPrice Monitoring Extension
17th Sep 20197:00 amRNSInterim Results
23rd Jul 20197:00 amRNSTrading Update and Notice of Results
22nd Jul 201911:54 amRNSExercise of Options
4th Jul 20197:00 amRNSCompany Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.